Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia.

As expected, we observed a highly significant difference between the two groups, where mRNA transcripts down-modulated by LDC526 exhibited ~ 2-fold higher decay rates, underpinning the proposed working mechanism as an inhibitor of de novo mRNA synthesis ( Figure 5E ).

also in 132,142 other papers